Last reviewed · How we verify
NCT03616275
Enhancing the Vagal Tone in Prediabetes Individuals
NA trial testing HRV biofeedback in Prediabetes in 90 participants. Completed in 31 July 2019.
31 July 2019
Quick facts
| Lead sponsor | National Defense Medical Center, Taiwan |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 90 |
| Start date | 17 October 2017 |
| Primary completion | 31 July 2019 |
| Estimated completion | 31 July 2019 |
| Sites | 1 location across Taiwan |
Drugs / interventions tested
- HRV biofeedback
Conditions studied
- Prediabetes — all drugs for Prediabetes →
- Autonomic Nervous System Imbalance — all drugs for Autonomic Nervous System Imbalance →
- Poor Glycemic Control — all drugs for Poor Glycemic Control →
- Psychological Distress — all drugs for Psychological Distress →
Sponsor
National Defense Medical Center, Taiwan
Who can join
20 and older, any sex, with Prediabetes or Autonomic Nervous System Imbalance. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a 2-year course of study. A randomized control trial will be conducted, in which 90 prediabetes individuals will be recruited and randomly assigned them into the wait-list control group or experimental group to test the effectiveness of 8 once-a-week, individual, 20-min sessions of HRV biofeedback on modulating vagal tone, glycemic control, psychological wellbeing, and inflammatory status in this population. Its longitudinal effects will be evaluated after 3- and 6-month follow-up.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03616275
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of HRV biofeedback
Trials testing the same drug.
- NCT06269536 — Stress-reducing Intervention in Urothelial Carcinoma · NA · recruiting
- NCT05917262 — Comparing Mindfulness-based Breath Training and Heart Rate Variability Biofeedback for Shoulder Surgery Patients in the · NA · recruiting
Other recruiting trials for Prediabetes
Currently open trials in the same condition.
- NCT07529366 — Pharmacist-Led Continuous Glucose Monitoring for Prediabetes · recruiting
- NCT07536256 — Community Connections Through Native Hawaiian Cultural Values to Strengthen Youth Resilience, Health, and Well-Being · NA · recruiting
- NCT07478263 — Behavioral Approach for Latinas Addressing Nutrition, Cravings, and Eating Patterns to Prevent Type 2 Diabetes · NA · recruiting
- NCT07491653 — Fiber mHealth Intervention for Prediabetes · NA · recruiting
- NCT07372729 — Smartwatch-based Intervention for Cardiovascular Health (SWITCH) · NA · recruiting
Other National Defense Medical Center, Taiwan trials
Trials by the same sponsor.
- NCT07373002 — Development and Evaluation of an Intelligent Parent-Infant Connection-Based Intervention to Strengthen Family Resilience · NA · not yet recruiting
- NCT07488052 — Home-based Outpatient Multicenter Evaluation Using Electrocardiogram (HOME-ECG) · recruiting
- NCT07307729 — AI-Enabled ECG Stratification and Timing of Potassium-Lowering Therapy in Patients With Hyperkalemia: A Target Trial Emu · NA · not yet recruiting
- NCT07217236 — Proactive Risk Evaluation for Cardiac Implantable Electronic Device Strategy Using AI-ECG · NA · recruiting
- NCT06887699 — The Impact of Artificial Intelligence Electrocardiography on Occlusion Myocardial Infarction Management Under the Value- · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03616275 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by National Defense Medical Center, Taiwan
- Last refreshed: 26 February 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03616275.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing